|
Proteins that
could lead to drugs that stop tumor growth and cancer have been
identified by Argonne biologists studying capillary formation,
or angiogenesis.
Argonne researchers
are the first to study the earliest steps in
capillary formation in tumors. They identified 280 proteins that
endothelial cells—cells that form blood vessels—secrete
in large quantities during capillary growth. Because proteins
are responsible for cellular structure and communication, biologists
want to learn which ones to block to develop a treatment that
arrests
tumor growth by halting capillary formation.
While anti-angiogenic
drugs have shown promise in laboratory studies, they have not
fared well in clinical trials. That is
because they
have targeted only individual molecular pathways, explained
Diane Rodi, a biologist in the Biosciences
Division. Researchers
expect
their in-depth angiogenesis work to find more effective treatments.
Current
cancer therapies attack fast-dividing cells, such as hair follicles
and the cells that line the gastrointestinal
tract, causing
side effects of nausea and hair loss.
“There
is not a lot of capillary growth in normal adults,” said
Rodi. “Humans only grow capillaries when healing from
an injury or during menstrual cycles. So if we can come
up with a cocktail
of drugs to knock out all capillary formation in the body,
it might be a method of treating cancer patients that does
not make them
sick.”
Capillaries
are a tumor’s lifeline, delivering
oxygen to and removing waste from it. Tumors use capillaries
to metastasize,
or spread to other body tissues. When malignant tumors
move to other body tissues, they crowd healthy cells
and prevent them from
functioning properly, making cancer fatal.
Capillaries
are formed by endothelial cells that create little hollow tubes.
When a tumor lacks oxygen, it sends
protein
signals toward existing capillaries. Endothelial cells
break off, releasing
enzymes that chew through body tissue toward the tumor
to make a new capillary.
Argonne’s
Angiogenesis Group mimics natural capillary formation. Endothelial
cells that have been isolated from human tissue and
mixed with growth factors are placed in a protein
gel.
The gel
acts like body tissue and causes the cells to release
enzymes.
Using a light
microscope attached to a digital camera, the group takes snapshots
of the cells and isolates
their ribonucleic
acid
(RNA) during the eight-hour capillary formation
process.
The biologists
identify the isolated RNA that codes for proteins to determine
what proteins the cells
produce at each time interval.
Also see: http://www.anl.gov/OPA/logos21-2/capillaries01.htm.
For more information,
please contact Evelyn Brown.
Next: Scientific
disciplines blur as researchers work
together to understand nanomaterial secrets
Back
to top
|